<!DOCTYPE html><html lang="en"><head><title>Help for package boinet</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link href="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/themes/prism.min.css" rel="stylesheet" />
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.css">
<script type="text/javascript">
const macros = { "\\R": "\\textsf{R}", "\\code": "\\texttt"};
function processMathHTML() {
    var l = document.getElementsByClassName('reqn');
    for (let e of l) { katex.render(e.textContent, e, { throwOnError: false, macros }); }
    return;
}</script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.js"
    onload="processMathHTML();"></script>
<link rel="stylesheet" type="text/css" href="R-nav.css" />
</head><body><div class="container"><nav class="package" aria-label="Topic Navigation">
<div class="dropdown-menu">
<h1>Package {boinet}</h1>
<h2>Contents</h2>
<ul class="menu">
<li><a href='#boinet'><p>Conducting simulation study of BOIN-ET design</p></a></li>
<li><a href='#fp.logit'><p>Fractional polynomial logistic regression</p></a></li>
<li><a href='#gboinet'><p>Conducting simulation study of gBOIN-ET design</p></a></li>
<li><a href='#gridoptim'><p>Grid search to find optimal threshold values of toxicity and efficacy interval</p></a></li>
<li><a href='#multi.iso'><p>Model averaging of multiple unimodal isotopic regression</p></a></li>
<li><a href='#obd.select'><p>Optimal biological dose selection</p></a></li>
<li><a href='#print.boinet'><p>Print boinet</p></a></li>
<li><a href='#print.gboinet'><p>Print gboinet</p></a></li>
<li><a href='#print.tite.boinet'><p>Print tite.boinet</p></a></li>
<li><a href='#print.tite.gboinet'><p>Print tite.gboinet</p></a></li>
<li><a href='#tite.boinet'><p>Conducting simulation study of TITE-BOIN-ET design</p></a></li>
<li><a href='#tite.gboinet'><p>Conducting simulation study of TITE-gBOIN-ET design</p></a></li>
<li><a href='#utility.scoring'><p>Utility defined by scoring</p></a></li>
<li><a href='#utility.truncated.linear'><p>Utility defined by truncated linear function</p></a></li>
<li><a href='#utility.weighted'><p>Utility defined by weighted function</p></a></li>
</ul>
</div>
<hr>
</nav>
<main>
<table role='presentation'>
<tr>
<td>Version:</td>
<td>1.1.0</td>
</tr>
<tr>
<td>Title:</td>
<td>Conduct Simulation Study of Bayesian Optimal Interval Design
with BOIN-ET Family</td>
</tr>
<tr>
<td>Description:</td>
<td>Bayesian optimal interval based on both efficacy and toxicity outcomes (BOIN-ET) design is a model-assisted oncology phase I/II trial design, aiming to establish an optimal biological dose accounting for efficacy and toxicity in the framework of dose-finding. Some extensions of BOIN-ET design are also available to allow for time-to-event efficacy and toxicity outcomes based on cumulative and pending data (time-to-event BOIN-ET: TITE-BOIN-ET), ordinal graded efficacy and toxicity outcomes (generalized BOIN-ET: gBOIN-ET), and their combination (TITE-gBOIN-ET). 'boinet' is a package to implement the BOIN-ET design family and supports the conduct of simulation studies to assess operating characteristics of BOIN-ET, TITE-BOIN-ET, gBOIN-ET, and TITE-gBOIN-ET, where users can choose design parameters in flexible and straightforward ways depending on their own application.</td>
</tr>
<tr>
<td>License:</td>
<td><a href="https://opensource.org/licenses/mit-license.php">MIT</a> + file LICENSE</td>
</tr>
<tr>
<td>Encoding:</td>
<td>UTF-8</td>
</tr>
<tr>
<td>RoxygenNote:</td>
<td>7.3.1</td>
</tr>
<tr>
<td>Imports:</td>
<td>Iso, mfp, copula</td>
</tr>
<tr>
<td>Suggests:</td>
<td>testthat (&ge; 3.0.0)</td>
</tr>
<tr>
<td>Config/testthat/edition:</td>
<td>3</td>
</tr>
<tr>
<td>NeedsCompilation:</td>
<td>no</td>
</tr>
<tr>
<td>Packaged:</td>
<td>2024-08-07 20:55:16 UTC; API18340</td>
</tr>
<tr>
<td>Author:</td>
<td>Yusuke Yamaguchi [aut, cre],
  Kentaro Takeda [aut]</td>
</tr>
<tr>
<td>Maintainer:</td>
<td>Yusuke Yamaguchi &lt;yamagubed@gmail.com&gt;</td>
</tr>
<tr>
<td>Repository:</td>
<td>CRAN</td>
</tr>
<tr>
<td>Date/Publication:</td>
<td>2024-08-24 06:20:02 UTC</td>
</tr>
</table>
<hr>
<h2 id='boinet'>Conducting simulation study of BOIN-ET design</h2><span id='topic+boinet'></span>

<h3>Description</h3>

<p>Bayesian optimal interval design for dose finding based on both efficacy
and toxicity outcomes (BOIN-ET design) is implemented under a scenario
specified. Operating characteristics of the design are summarized by the
percentage of times that each dose level was selected as optimal biological
dose and the average number of patients who were treated at each dose level.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>boinet(
  n.dose, start.dose, size.cohort, n.cohort,
  toxprob, effprob,
  phi=0.3, phi1=phi*0.1, phi2=phi*1.4, delta=0.6, delta1=delta*0.6,
  alpha.T1=0.5, alpha.E1=0.5, tau.T, tau.E,
  te.corr=0.2, gen.event.time="weibull",
  accrual, gen.enroll.time="uniform",
  stopping.npts=size.cohort*n.cohort,
  stopping.prob.T=0.95, stopping.prob.E=0.99,
  estpt.method, obd.method,
  w1= 0.33, w2=1.09,
  plow.ast=phi1, pupp.ast=phi2, qlow.ast=delta1/2, qupp.ast=delta,
  psi00=40, psi11=60,
  n.sim=1000, seed.sim=100)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="boinet_+3A_n.dose">n.dose</code></td>
<td>
<p>Number of dose.</p>
</td></tr>
<tr><td><code id="boinet_+3A_start.dose">start.dose</code></td>
<td>
<p>Starting dose. The lowest dose is generally recommended.</p>
</td></tr>
<tr><td><code id="boinet_+3A_size.cohort">size.cohort</code></td>
<td>
<p>Cohort size.</p>
</td></tr>
<tr><td><code id="boinet_+3A_n.cohort">n.cohort</code></td>
<td>
<p>Number of cohort.</p>
</td></tr>
<tr><td><code id="boinet_+3A_toxprob">toxprob</code></td>
<td>
<p>Vector of true toxicity probability.</p>
</td></tr>
<tr><td><code id="boinet_+3A_effprob">effprob</code></td>
<td>
<p>Vector of true efficacy probability.</p>
</td></tr>
<tr><td><code id="boinet_+3A_phi">phi</code></td>
<td>
<p>Target toxicity probability. The default value is
<code>phi=0.3</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_phi1">phi1</code></td>
<td>
<p>Highest toxicity probability that is deemed sub-therapeutic such
that dose-escalation should be pursued. The default value is
<code>phi1=phi*0.1</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_phi2">phi2</code></td>
<td>
<p>Lowest toxicity probability that is deemed overly toxic such that
dose de-escalation is needed. The default value is <code>phi2=phi*1.4</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_delta">delta</code></td>
<td>
<p>Target efficacy probability. The default value is
<code>delta=0.6</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_delta1">delta1</code></td>
<td>
<p>Minimum probability deemed efficacious such that the dose
levels with less than delta1 are considered sub-therapeutic.
The default value is <code>delta1=delta*0.6</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_alpha.t1">alpha.T1</code></td>
<td>
<p>Probability that toxicity event occurs in the late half of
toxicity assessment window. The default value is <code>alpha.T1=0.5</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_alpha.e1">alpha.E1</code></td>
<td>
<p>Probability that efficacy event occurs in the late half of
assessment window. The default value is <code>alpha.E1=0.5</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_tau.t">tau.T</code></td>
<td>
<p>Toxicity assessment windows (days).</p>
</td></tr>
<tr><td><code id="boinet_+3A_tau.e">tau.E</code></td>
<td>
<p>Efficacy assessment windows (days).</p>
</td></tr>
<tr><td><code id="boinet_+3A_te.corr">te.corr</code></td>
<td>
<p>Correlation between toxicity and efficacy probability,
specified as Gaussian copula parameter. The default value is
<code>te.corr=0.2</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_gen.event.time">gen.event.time</code></td>
<td>
<p>Method to generate the time to first toxicity and
efficacy outcome. Weibull distribution is used when
<code>gen.event.time="weibull"</code>. Uniform distribution is used when
<code>gen.event.time="uniform"</code>. The default value is
<code>gen.event.time="weibull"</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_accrual">accrual</code></td>
<td>
<p>Accrual rate (days) (average number of days necessary to
enroll one patient).</p>
</td></tr>
<tr><td><code id="boinet_+3A_gen.enroll.time">gen.enroll.time</code></td>
<td>
<p>Method to generate enrollment time. Uniform
distribution is used when <code>gen.enroll.time="uniform"</code>. Exponential
distribution is used when <code>gen.enroll.time="exponential"</code>. The default
value is <code>gen.enroll.time="uniform"</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_stopping.npts">stopping.npts</code></td>
<td>
<p>Early study termination criteria for the number of
patients. If the number of patients at the current dose reaches this
criteria, the study is terminated. The default value is
<code>stopping.npts=size.cohort*n.cohort</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_stopping.prob.t">stopping.prob.T</code></td>
<td>
<p>Early study termination criteria for toxicity,
taking a value between 0 and 1. If the posterior probability that toxicity
outcome is less than the target toxicity probability (<code>phi</code>) is larger than
this criteria, the dose levels are eliminated from the study. The default
value is <code>stopping.prob.T=0.95</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_stopping.prob.e">stopping.prob.E</code></td>
<td>
<p>Early study termination criteria for efficacy,
taking a value between 0 and 1. If the posterior probability that efficacy
outcome is less than the minimum efficacy probability (<code>delta1</code>) is larger
than this criteria, the dose levels are eliminated from the study.
The default value is <code>stopping.prob.E=0.99</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_estpt.method">estpt.method</code></td>
<td>
<p>Method to estimate the efficacy probability. Fractional
polynomial logistic regression is used when <code>estpt.method="fp.logistic"</code>.
Model averaging of multiple unimodal isotopic regression is used when
<code>estpt.method="multi.iso"</code>. Observed efficacy probability is used when
<code>estpt.method="obs.prob"</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_obd.method">obd.method</code></td>
<td>
<p>Method to select the optimal biological dose. Utility
defined by weighted function is used when <code>obd.method="utility.weighted"</code>.
Utility defined by truncated linear function is used when
<code>obd.method="utility.truncated.linear"</code>. Utility defined by scoring is
used when <code>obd.method="utility.scoring"</code>. Highest estimated efficacy
probability is used when <code>obd.method="max.effprob"</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_w1">w1</code></td>
<td>
<p>Weight for toxicity-efficacy trade-off in utility defined by
weighted function. This must be specified when using
<code>obd.method="utility.weighted"</code>. The default value is <code>w1=0.33</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_w2">w2</code></td>
<td>
<p>Weight for penalty imposed on toxic doses in utility defined by
weighted function. This must be specified when using
<code>obd.method="utility.weighted"</code>. The default value is <code>w2=1.09</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_plow.ast">plow.ast</code></td>
<td>
<p>Lower threshold of toxicity linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>plow.ast=phi1</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_pupp.ast">pupp.ast</code></td>
<td>
<p>Upper threshold of toxicity linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>pupp.ast=phi2</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_qlow.ast">qlow.ast</code></td>
<td>
<p>Lower threshold of efficacy linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>qlow.ast=delta1/2</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_qupp.ast">qupp.ast</code></td>
<td>
<p>Upper threshold of efficacy linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>qupp.ast=delta</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_psi00">psi00</code></td>
<td>
<p>Score for toxicity=no and efficacy=no in utility defined by
scoring. This must be specified when using <code>obd.method="utility.scoring"</code>.
The default value is <code>psi00=40</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_psi11">psi11</code></td>
<td>
<p>Score for toxicity=yes and efficacy=yes in utility defined by
scoring. This must be specified when using <code>obd.method="utility.scoring"</code>.
The default value is <code>psi11=60</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_n.sim">n.sim</code></td>
<td>
<p>Number of simulated trial. The default value is
<code>n.sim=1000</code>.</p>
</td></tr>
<tr><td><code id="boinet_+3A_seed.sim">seed.sim</code></td>
<td>
<p>Seed for random number generator. The default value is
<code>seed.sim=100</code>.</p>
</td></tr>
</table>


<h3>Details</h3>

<p>The <code>boinet</code> is a function which generates the operating
characteristics of the Bayesian Optimal Interval design based on toxicity
and efficacy (BOIN-ET design) by a simulation study. Users can specify a
variety of study settings to simulate studies, and choose methods to estimate
the efficacy probability and to select the optimal biological dose. The
operating characteristics of the design are summarized by the percentage of
times that each dose level was selected as optimal biological dose and the
average number of patients who were treated at each dose level. The
percentage of times that the study was terminated and the expected study
duration are also provided.
</p>


<h3>Value</h3>

<p>The <code>boinet</code> returns a list containing the following components:
</p>
<table role = "presentation">
<tr><td><code>toxprob</code></td>
<td>
<p>True toxicity probability.</p>
</td></tr>
<tr><td><code>effprob</code></td>
<td>
<p>True efficacy probability.</p>
</td></tr>
<tr><td><code>phi</code></td>
<td>
<p>Target toxicity probability.</p>
</td></tr>
<tr><td><code>delta</code></td>
<td>
<p>Target efficacy probability.</p>
</td></tr>
<tr><td><code>lambda1</code></td>
<td>
<p>Lower toxicity boundary in dose escalation/de-escalation.</p>
</td></tr>
<tr><td><code>lambda2</code></td>
<td>
<p>Upper toxicity boundary in dose escalation/de-escalation.</p>
</td></tr>
<tr><td><code>eta1</code></td>
<td>
<p>Lower efficacy boundary in dose escalation/de-escalation.</p>
</td></tr>
<tr><td><code>tau.T</code></td>
<td>
<p>Toxicity assessment windows (days).</p>
</td></tr>
<tr><td><code>tau.E</code></td>
<td>
<p>Efficacy assessment windows (days).</p>
</td></tr>
<tr><td><code>accrual</code></td>
<td>
<p>Accrual rate (days) (average number of days necessary to
enroll one patient).</p>
</td></tr>
<tr><td><code>estpt.method</code></td>
<td>
<p>Method to estimate the efficacy probability.</p>
</td></tr>
<tr><td><code>obd.method</code></td>
<td>
<p>Method to select the optimal biological dose.</p>
</td></tr>
<tr><td><code>n.patient</code></td>
<td>
<p>Average number of patients who were treated at each dose
level</p>
</td></tr>
<tr><td><code>prop.select</code></td>
<td>
<p>Percentage of times that each dose level was selected as
optimal biological dose.</p>
</td></tr>
<tr><td><code>prop.stop</code></td>
<td>
<p>Percentage of times that the study was terminated and
optimal biological dose was not selected.</p>
</td></tr>
<tr><td><code>duration</code></td>
<td>
<p>Expected study duration (days)</p>
</td></tr>
</table>


<h3>References</h3>

<p>Takeda K, Taguri M, Morita S. BOIN-ET: Bayesian optimal interval design
for dose finding based on both efficacy and toxicity outcomes.
<em>Pharmaceutical Statistics</em> 2018; 17(4):383-395.
</p>
<p>Yamaguchi Y, Takeda K, Yoshida S, Maruo K. Optimal biological dose selection
in dose-finding trials with model-assisted designs based on efficacy and
toxicity: a simulation study. <em>Journal of Biopharmaceutical Statistics</em> 2023;
doi: 10.1080/10543406.2023.2202259.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>n.dose      &lt;- 6
start.dose  &lt;- 1
size.cohort &lt;- 3
n.cohort    &lt;- 12

toxprob &lt;- c(0.01,0.03,0.06,0.12,0.18,0.30)
effprob &lt;- c(0.06,0.08,0.15,0.25,0.40,0.80)

phi   &lt;- 0.33
delta &lt;- 0.70

tau.T   &lt;- 30
tau.E   &lt;- 45
accrual &lt;- 10

estpt.method &lt;- "obs.prob"
obd.method   &lt;- "max.effprob"

n.sim &lt;- 10

boinet(
  n.dose=n.dose, start.dose=start.dose,
  size.cohort=size.cohort, n.cohort=n.cohort,
  toxprob=toxprob, effprob=effprob,
  phi=phi, delta=delta,
  tau.T=tau.T, tau.E=tau.E, accrual=accrual,
  estpt.method=estpt.method, obd.method=obd.method,
  n.sim=n.sim)
</code></pre>

<hr>
<h2 id='fp.logit'>Fractional polynomial logistic regression</h2><span id='topic+fp.logit'></span>

<h3>Description</h3>

<p>Fractional polynomial (FP) logistic regression with two degrees of freedom is
performed to estimate the efficacy probabilities. The Best fitting FP model is
chosen by not taking into account the closed testing procedure.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>fp.logit(obs, n, dose)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="fp.logit_+3A_obs">obs</code></td>
<td>
<p>Number of patients with events.</p>
</td></tr>
<tr><td><code id="fp.logit_+3A_n">n</code></td>
<td>
<p>Number of patients.</p>
</td></tr>
<tr><td><code id="fp.logit_+3A_dose">dose</code></td>
<td>
<p>Dose levels to be investigated.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>The <code>fp.logit</code> returns a vector of estimated probabilities for
each dose level.
</p>

<hr>
<h2 id='gboinet'>Conducting simulation study of gBOIN-ET design</h2><span id='topic+gboinet'></span>

<h3>Description</h3>

<p>Generalized Bayesian optimal interval design for optimal dose-finding
accounting for ordinal graded efficacy and toxicity (gBOIN-ET design) is
implemented under a scenario specified. Operating characteristics of the
design are summarized by the percentage of times that each dose level was
selected as optimal biological dose and the average number of patients who
were treated at each dose level.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>gboinet(
  n.dose, start.dose, size.cohort, n.cohort,
  toxprob, effprob, sev.weight, res.weight,
  phi, phi1=phi*0.1, phi2=phi*1.4, delta, delta1=delta*0.6,
  alpha.T1=0.5, alpha.E1=0.5, tau.T, tau.E,
  te.corr=0.2, gen.event.time="weibull",
  accrual, gen.enroll.time="uniform",
  stopping.npts=size.cohort*n.cohort,
  stopping.prob.T=0.95, stopping.prob.E=0.99,
  estpt.method, obd.method,
  w1=0.33, w2=1.09,
  plow.ast=phi1, pupp.ast=phi2, qlow.ast=delta1/2, qupp.ast=delta,
  psi00=40, psi11=60,
  n.sim=1000, seed.sim=100)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="gboinet_+3A_n.dose">n.dose</code></td>
<td>
<p>Number of dose.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_start.dose">start.dose</code></td>
<td>
<p>Starting dose. The lowest dose is generally recommended.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_size.cohort">size.cohort</code></td>
<td>
<p>Cohort size.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_n.cohort">n.cohort</code></td>
<td>
<p>Number of cohort.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_toxprob">toxprob</code></td>
<td>
<p>Vector of true toxicity probability.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_effprob">effprob</code></td>
<td>
<p>Vector of true efficacy probability.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_sev.weight">sev.weight</code></td>
<td>
<p>Vector of weight for toxicity category.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_res.weight">res.weight</code></td>
<td>
<p>Vector of weight for efficacy category.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_phi">phi</code></td>
<td>
<p>Target toxicity probability.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_phi1">phi1</code></td>
<td>
<p>Highest toxicity probability that is deemed sub-therapeutic such
that dose-escalation should be pursued. The default value is
<code>phi1=phi*0.1</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_phi2">phi2</code></td>
<td>
<p>Lowest toxicity probability that is deemed overly toxic such that
dose de-escalation is needed. The default value is <code>phi2=phi*1.4</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_delta">delta</code></td>
<td>
<p>Target efficacy probability.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_delta1">delta1</code></td>
<td>
<p>Minimum probability deemed efficacious such that the dose
levels with less than delta1 are considered sub-therapeutic.
The default value is <code>delta1=delta*0.6</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_alpha.t1">alpha.T1</code></td>
<td>
<p>Probability that toxicity event occurs in the late half of
toxicity assessment window. The default value is <code>alpha.T1=0.5</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_alpha.e1">alpha.E1</code></td>
<td>
<p>Probability that efficacy event occurs in the late half of
assessment window. The default value is <code>alpha.E1=0.5</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_tau.t">tau.T</code></td>
<td>
<p>Toxicity assessment windows (days).</p>
</td></tr>
<tr><td><code id="gboinet_+3A_tau.e">tau.E</code></td>
<td>
<p>Efficacy assessment windows (days).</p>
</td></tr>
<tr><td><code id="gboinet_+3A_te.corr">te.corr</code></td>
<td>
<p>Correlation between toxicity and efficacy probability,
specified as Gaussian copula parameter. The default value is
<code>te.corr=0.2</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_gen.event.time">gen.event.time</code></td>
<td>
<p>Method to generate the time to first toxicity and
efficacy outcome. Weibull distribution is used when
<code>gen.event.time="weibull"</code>. Uniform distribution is used when
<code>gen.event.time="uniform"</code>. The default value is
<code>gen.event.time="weibull"</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_accrual">accrual</code></td>
<td>
<p>Accrual rate (days) (average number of days necessary to
enroll one patient).</p>
</td></tr>
<tr><td><code id="gboinet_+3A_gen.enroll.time">gen.enroll.time</code></td>
<td>
<p>Method to generate enrollment time. Uniform
distribution is used when <code>gen.enroll.time="uniform"</code>. Exponential
distribution is used when <code>gen.enroll.time="exponential"</code>. The default
value is <code>gen.enroll.time="uniform"</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_stopping.npts">stopping.npts</code></td>
<td>
<p>Early study termination criteria for the number of
patients. If the number of patients at the current dose reaches this
criteria, the study is terminated. The default value is
<code>stopping.npts=size.cohort*n.cohort</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_stopping.prob.t">stopping.prob.T</code></td>
<td>
<p>Early study termination criteria for toxicity,
taking a value between 0 and 1. If the posterior probability that toxicity
outcome is less than the target toxicity probability (<code>phi</code>) is larger than
this criteria, the dose levels are eliminated from the study. The default
value is <code>stopping.prob.T=0.95</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_stopping.prob.e">stopping.prob.E</code></td>
<td>
<p>Early study termination criteria for efficacy,
taking a value between 0 and 1. If the posterior probability that efficacy
outcome is less than the minimum efficacy probability (<code>delta1</code>) is larger
than this criteria, the dose levels are eliminated from the study.
The default value is <code>stopping.prob.E=0.99</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_estpt.method">estpt.method</code></td>
<td>
<p>Method to estimate the efficacy probability. Fractional
polynomial logistic regression is used when <code>estpt.method="fp.logistic"</code>.
Model averaging of multiple unimodal isotopic regression is used when
<code>estpt.method="multi.iso"</code>. Observed efficacy probability is used when
<code>estpt.method="obs.prob"</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_obd.method">obd.method</code></td>
<td>
<p>Method to select the optimal biological dose. Utility
defined by weighted function is used when <code>obd.method="utility.weighted"</code>.
Utility defined by truncated linear function is used when
<code>obd.method="utility.truncated.linear"</code>. Utility defined by scoring is
used when <code>obd.method="utility.scoring"</code>. Highest estimated efficacy
probability is used when <code>obd.method="max.effprob"</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_w1">w1</code></td>
<td>
<p>Weight for toxicity-efficacy trade-off in utility defined by
weighted function. This must be specified when using
<code>obd.method="utility.weighted"</code>. The default value is <code>w1=0.33</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_w2">w2</code></td>
<td>
<p>Weight for penalty imposed on toxic doses in utility defined by
weighted function. This must be specified when using
<code>obd.method="utility.weighted"</code>. The default value is <code>w2=1.09</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_plow.ast">plow.ast</code></td>
<td>
<p>Lower threshold of toxicity linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>plow.ast=phi1</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_pupp.ast">pupp.ast</code></td>
<td>
<p>Upper threshold of toxicity linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>pupp.ast=phi2</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_qlow.ast">qlow.ast</code></td>
<td>
<p>Lower threshold of efficacy linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>qlow.ast=delta1/2</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_qupp.ast">qupp.ast</code></td>
<td>
<p>Upper threshold of efficacy linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>qupp.ast=delta</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_psi00">psi00</code></td>
<td>
<p>Score for toxicity=no and efficacy=no in utility defined by
scoring. This must be specified when using <code>obd.method="utility.scoring"</code>.
The default value is <code>psi00=40</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_psi11">psi11</code></td>
<td>
<p>Score for toxicity=yes and efficacy=yes in utility defined by
scoring. This must be specified when using <code>obd.method="utility.scoring"</code>.
The default value is <code>psi11=60</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_n.sim">n.sim</code></td>
<td>
<p>Number of simulated trial. The default value is
<code>n.sim=1000</code>.</p>
</td></tr>
<tr><td><code id="gboinet_+3A_seed.sim">seed.sim</code></td>
<td>
<p>Seed for random number generator. The default value is
<code>seed.sim=100</code>.</p>
</td></tr>
</table>


<h3>Details</h3>

<p>The <code>gboinet</code> is a function which generates the operating
characteristics of the generalized Bayesian optimal interval design for
optimal dose-finding accounting for ordinal graded efficacy and toxicity
(gBOIN-ET design) by a simulation study. Users can specify a
variety of study settings to simulate studies, and choose methods to estimate
the efficacy probability and to select the optimal biological dose. The
operating characteristics of the design are summarized by the percentage of
times that each dose level was selected as optimal biological dose and the
average number of patients who were treated at each dose level. The
percentage of times that the study was terminated and the expected study
duration are also provided.
</p>


<h3>Value</h3>

<p>The <code>gboinet</code> returns a list containing the following components:
</p>
<table role = "presentation">
<tr><td><code>toxprob</code></td>
<td>
<p>True toxicity probability.</p>
</td></tr>
<tr><td><code>effprob</code></td>
<td>
<p>True efficacy probability.</p>
</td></tr>
<tr><td><code>nETS</code></td>
<td>
<p>Normalized equivalent toxicity score.</p>
</td></tr>
<tr><td><code>nEES</code></td>
<td>
<p>Normalized equivalent efficacy score.</p>
</td></tr>
<tr><td><code>phi</code></td>
<td>
<p>Target toxicity probability.</p>
</td></tr>
<tr><td><code>delta</code></td>
<td>
<p>Target efficacy probability.</p>
</td></tr>
<tr><td><code>lambda1</code></td>
<td>
<p>Lower toxicity boundary in dose escalation/de-escalation.</p>
</td></tr>
<tr><td><code>lambda2</code></td>
<td>
<p>Upper toxicity boundary in dose escalation/de-escalation.</p>
</td></tr>
<tr><td><code>eta1</code></td>
<td>
<p>Lower efficacy boundary in dose escalation/de-escalation.</p>
</td></tr>
<tr><td><code>tau.T</code></td>
<td>
<p>Toxicity assessment windows (days).</p>
</td></tr>
<tr><td><code>tau.E</code></td>
<td>
<p>Efficacy assessment windows (days).</p>
</td></tr>
<tr><td><code>accrual</code></td>
<td>
<p>Accrual rate (days) (average number of days necessary to
enroll one patient).</p>
</td></tr>
<tr><td><code>estpt.method</code></td>
<td>
<p>Method to estimate the efficacy probability.</p>
</td></tr>
<tr><td><code>obd.method</code></td>
<td>
<p>Method to select the optimal biological dose.</p>
</td></tr>
<tr><td><code>n.patient</code></td>
<td>
<p>Average number of patients who were treated at each dose
level</p>
</td></tr>
<tr><td><code>prop.select</code></td>
<td>
<p>Percentage of times that each dose level was selected as
optimal biological dose.</p>
</td></tr>
<tr><td><code>prop.stop</code></td>
<td>
<p>Percentage of times that the study was terminated and
optimal biological dose was not selected.</p>
</td></tr>
<tr><td><code>duration</code></td>
<td>
<p>Expected study duration (days)</p>
</td></tr>
</table>


<h3>References</h3>

<p>Takeda K, Morita S, Taguri M. gBOIN-ET: The generalized Bayesian optimal
interval design for optimal dose-finding accounting for ordinal graded
efficacy and toxicity in early clinical trials. <em>Biometrical Journal</em> 2022:
64(7):1178-1191.
</p>
<p>Yamaguchi Y, Takeda K, Yoshida S, Maruo K. Optimal biological dose selection
in dose-finding trials with model-assisted designs based on efficacy and
toxicity: a simulation study. <em>Journal of Biopharmaceutical Statistics</em> 2023;
doi: 10.1080/10543406.2023.2202259.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>n.dose      &lt;- 6
start.dose  &lt;- 1
size.cohort &lt;- 3
n.cohort    &lt;- 12

toxprob &lt;- rbind(c(0.94,0.87,0.79,0.68,0.62,0.50),
                 c(0.05,0.10,0.15,0.20,0.20,0.20),
                 c(0.01,0.03,0.05,0.10,0.15,0.25),
                 c(0.00,0.00,0.01,0.02,0.03,0.05))
effprob &lt;- rbind(c(0.64,0.52,0.45,0.35,0.20,0.05),
                 c(0.30,0.40,0.40,0.40,0.40,0.15),
                 c(0.05,0.05,0.10,0.15,0.20,0.35),
                 c(0.01,0.03,0.05,0.10,0.20,0.45))

sev.weight &lt;- c(0.00,0.50,1.00,1.50)
res.weight &lt;- c(0.00,0.25,1.00,3.00)

phi   &lt;- 0.33
delta &lt;- 0.70

tau.T   &lt;- 30
tau.E   &lt;- 45
accrual &lt;- 10

estpt.method &lt;- "obs.prob"
obd.method   &lt;- "max.effprob"

n.sim &lt;- 10

gboinet(
  n.dose=n.dose, start.dose=start.dose,
  size.cohort=size.cohort, n.cohort=n.cohort,
  toxprob=toxprob, effprob=effprob,
  sev.weight=sev.weight, res.weight=res.weight,
  phi=phi, delta=delta,
  tau.T=tau.T, tau.E=tau.E, accrual=accrual,
  estpt.method=estpt.method, obd.method=obd.method,
  n.sim=n.sim)
</code></pre>

<hr>
<h2 id='gridoptim'>Grid search to find optimal threshold values of toxicity and efficacy interval</h2><span id='topic+gridoptim'></span>

<h3>Description</h3>

<p>Given non-informative prior probabilities of the six hypotheses, a grid
search approach is used to find the optimal threshold values.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>gridoptim(pi=rep(1/6,6), phi, phi1, phi2, delta, delta1, n=100)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="gridoptim_+3A_pi">pi</code></td>
<td>
<p>Prior probability of 6 hypotheses. The default value is
<code>pi=rep(1/6,6)</code>.</p>
</td></tr>
<tr><td><code id="gridoptim_+3A_phi">phi</code></td>
<td>
<p>Target toxicity probability.</p>
</td></tr>
<tr><td><code id="gridoptim_+3A_phi1">phi1</code></td>
<td>
<p>Lower bound of toxicity probability.</p>
</td></tr>
<tr><td><code id="gridoptim_+3A_phi2">phi2</code></td>
<td>
<p>Upper bound of toxicity probability.</p>
</td></tr>
<tr><td><code id="gridoptim_+3A_delta">delta</code></td>
<td>
<p>Target efficacy probability.</p>
</td></tr>
<tr><td><code id="gridoptim_+3A_delta1">delta1</code></td>
<td>
<p>Lower bound of efficacy probability.</p>
</td></tr>
<tr><td><code id="gridoptim_+3A_n">n</code></td>
<td>
<p>Number of patients. The default value is <code>n=100</code>.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>The <code>gridoptim</code> returns optimal threshold values of upper and
lower toxicity/efficacy boundaries used in dose-escalation procedure.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>gridoptim(phi=0.33,phi1=0.033,phi2=0.462,delta=0.70,delta1=0.42);
</code></pre>

<hr>
<h2 id='multi.iso'>Model averaging of multiple unimodal isotopic regression</h2><span id='topic+multi.iso'></span>

<h3>Description</h3>

<p>Given the location of the mode to be at each dose level, the unimodal
isotonically transformed values are calculated. A frequentist model
averaging approach is used to obtain the estimated efficacy probability.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>multi.iso(obs, n)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="multi.iso_+3A_obs">obs</code></td>
<td>
<p>Number of patients with events.</p>
</td></tr>
<tr><td><code id="multi.iso_+3A_n">n</code></td>
<td>
<p>Number of patients.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>The <code>multi.iso</code> returns a vector of estimated probabilities for
each dose level.
</p>

<hr>
<h2 id='obd.select'>Optimal biological dose selection</h2><span id='topic+obd.select'></span>

<h3>Description</h3>

<p>Optimal biological dose (OBD) is selected by a method specified.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>obd.select(
  probt, probe, method,
  phi, phi1, phi2, delta, delta1,
  tterm, eterm, stopT, stopE,
  w1, w2,
  plow.ast, pupp.ast, qlow.ast, qupp.ast,
  psi00, psi11)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="obd.select_+3A_probt">probt</code></td>
<td>
<p>Estimated toxicity probability.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_probe">probe</code></td>
<td>
<p>Estimated efficacy probability.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_method">method</code></td>
<td>
<p>Method used for OBD selection.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_phi">phi</code></td>
<td>
<p>Target toxicity probability.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_phi1">phi1</code></td>
<td>
<p>Lower bound of toxicity probability.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_phi2">phi2</code></td>
<td>
<p>Upper bound of toxicity probability.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_delta">delta</code></td>
<td>
<p>Target efficacy probability.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_delta1">delta1</code></td>
<td>
<p>Lower bound of efficacy probability.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_tterm">tterm</code></td>
<td>
<p>Probability of meeting toxicity stopping criteria.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_eterm">eterm</code></td>
<td>
<p>Probability of meeting efficacy stopping criteria.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_stopt">stopT</code></td>
<td>
<p>Toxicity stopping criteria.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_stope">stopE</code></td>
<td>
<p>Efficacy stopping criteria.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_w1">w1</code></td>
<td>
<p>Weight for toxicity-efficacy trade-off.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_w2">w2</code></td>
<td>
<p>Weight for penalty imposed on toxic doses.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_plow.ast">plow.ast</code></td>
<td>
<p>Lower threshold of toxicity linear truncated function.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_pupp.ast">pupp.ast</code></td>
<td>
<p>Upper threshold of toxicity linear truncated function.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_qlow.ast">qlow.ast</code></td>
<td>
<p>Lower threshold of efficacy linear truncated function.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_qupp.ast">qupp.ast</code></td>
<td>
<p>Upper threshold of efficacy linear truncated function.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_psi00">psi00</code></td>
<td>
<p>Score for toxicity=no and efficacy=no.</p>
</td></tr>
<tr><td><code id="obd.select_+3A_psi11">psi11</code></td>
<td>
<p>Score for toxicity=yes and efficacy=yes.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>The <code>obd.select</code> returns an optimal biological dose.
</p>

<hr>
<h2 id='print.boinet'>Print boinet</h2><span id='topic+print.boinet'></span>

<h3>Description</h3>

<p>Display key summary results from <code>boinet</code>.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>## S3 method for class 'boinet'
print(x, ...)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="print.boinet_+3A_x">x</code></td>
<td>
<p>Object from <code>boinet</code>.</p>
</td></tr>
<tr><td><code id="print.boinet_+3A_...">...</code></td>
<td>
<p>More options to pass to print.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>No return values. Key summary results from <code>boinet</code> are displayed with
trial design settings.
</p>


<h3>See Also</h3>

<p><code><a href="#topic+boinet">boinet</a></code>
</p>

<hr>
<h2 id='print.gboinet'>Print gboinet</h2><span id='topic+print.gboinet'></span>

<h3>Description</h3>

<p>Display key summary results from <code>gboinet</code>.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>## S3 method for class 'gboinet'
print(x, ...)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="print.gboinet_+3A_x">x</code></td>
<td>
<p>Object from <code>gboinet</code>.</p>
</td></tr>
<tr><td><code id="print.gboinet_+3A_...">...</code></td>
<td>
<p>More options to pass to print.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>No return values. Key summary results from <code>gboinet</code> are displayed with
trial design settings.
</p>


<h3>See Also</h3>

<p><code><a href="#topic+gboinet">gboinet</a></code>
</p>

<hr>
<h2 id='print.tite.boinet'>Print tite.boinet</h2><span id='topic+print.tite.boinet'></span>

<h3>Description</h3>

<p>Display key summary results from <code>tite.boinet</code>.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>## S3 method for class 'tite.boinet'
print(x, ...)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="print.tite.boinet_+3A_x">x</code></td>
<td>
<p>Object from <code>tite.boinet</code>.</p>
</td></tr>
<tr><td><code id="print.tite.boinet_+3A_...">...</code></td>
<td>
<p>More options to pass to print.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>No return values. Key summary results from <code>tite.boinet</code> are displayed with
trial design settings.
</p>


<h3>See Also</h3>

<p><code><a href="#topic+tite.boinet">tite.boinet</a></code>
</p>

<hr>
<h2 id='print.tite.gboinet'>Print tite.gboinet</h2><span id='topic+print.tite.gboinet'></span>

<h3>Description</h3>

<p>Display key summary results from <code>tite.gboinet</code>.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>## S3 method for class 'tite.gboinet'
print(x, ...)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="print.tite.gboinet_+3A_x">x</code></td>
<td>
<p>Object from <code>tite.gboinet</code>.</p>
</td></tr>
<tr><td><code id="print.tite.gboinet_+3A_...">...</code></td>
<td>
<p>More options to pass to print.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>No return values. Key summary results from <code>tite.gboinet</code> are displayed with
trial design settings.
</p>


<h3>See Also</h3>

<p><code><a href="#topic+tite.gboinet">tite.gboinet</a></code>
</p>

<hr>
<h2 id='tite.boinet'>Conducting simulation study of TITE-BOIN-ET design</h2><span id='topic+tite.boinet'></span>

<h3>Description</h3>

<p>Time-to-event Bayesian optimal interval design to accelerate dose-finding
based on both efficacy and toxicity outcomes (TITE-BOIN-ET design) is
implemented under a scenario
specified. Operating characteristics of the design are summarized by the
percentage of times that each dose level was selected as optimal biological
dose and the average number of patients who were treated at each dose level.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>tite.boinet(
  n.dose, start.dose, size.cohort, n.cohort,
  toxprob, effprob,
  phi=0.3, phi1=phi*0.1, phi2=phi*1.4, delta=0.6, delta1=delta*0.6,
  alpha.T1=0.5, alpha.E1=0.5, tau.T, tau.E,
  te.corr=0.2, gen.event.time="weibull",
  accrual, gen.enroll.time="uniform",
  stopping.npts=size.cohort*n.cohort,
  stopping.prob.T=0.95, stopping.prob.E=0.99,
  estpt.method, obd.method,
  w1= 0.33, w2=1.09,
  plow.ast=phi1, pupp.ast=phi2, qlow.ast=delta1/2, qupp.ast=delta,
  psi00=40, psi11=60,
  n.sim=1000, seed.sim=100)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="tite.boinet_+3A_n.dose">n.dose</code></td>
<td>
<p>Number of dose.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_start.dose">start.dose</code></td>
<td>
<p>Starting dose. The lowest dose is generally recommended.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_size.cohort">size.cohort</code></td>
<td>
<p>Cohort size.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_n.cohort">n.cohort</code></td>
<td>
<p>Number of cohort.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_toxprob">toxprob</code></td>
<td>
<p>Vector of true toxicity probability.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_effprob">effprob</code></td>
<td>
<p>Vector of true efficacy probability.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_phi">phi</code></td>
<td>
<p>Target toxicity probability. The default value is
<code>phi=0.3</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_phi1">phi1</code></td>
<td>
<p>Highest toxicity probability that is deemed sub-therapeutic such
that dose-escalation should be pursued. The default value is
<code>phi1=phi*0.1</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_phi2">phi2</code></td>
<td>
<p>Lowest toxicity probability that is deemed overly toxic such that
dose de-escalation is needed. The default value is <code>phi2=phi*1.4</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_delta">delta</code></td>
<td>
<p>Target efficacy probability. The default value is
<code>delta=0.6</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_delta1">delta1</code></td>
<td>
<p>Minimum probability deemed efficacious such that the dose
levels with less than delta1 are considered sub-therapeutic.
The default value is <code>delta1=delta*0.6</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_alpha.t1">alpha.T1</code></td>
<td>
<p>Probability that toxicity event occurs in the late half of
toxicity assessment window. The default value is <code>alpha.T1=0.5</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_alpha.e1">alpha.E1</code></td>
<td>
<p>Probability that efficacy event occurs in the late half of
assessment window. The default value is <code>alpha.E1=0.5</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_tau.t">tau.T</code></td>
<td>
<p>Toxicity assessment windows (days).</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_tau.e">tau.E</code></td>
<td>
<p>Efficacy assessment windows (days).</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_te.corr">te.corr</code></td>
<td>
<p>Correlation between toxicity and efficacy probability,
specified as Gaussian copula parameter. The default value is
<code>te.corr=0.2</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_gen.event.time">gen.event.time</code></td>
<td>
<p>Method to generate the time to first toxicity and
efficacy outcome. Weibull distribution is used when
<code>gen.event.time="weibull"</code>. Uniform distribution is used when
<code>gen.event.time="uniform"</code>. The default value is
<code>gen.event.time="weibull"</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_accrual">accrual</code></td>
<td>
<p>Accrual rate (days) (average number of days necessary to
enroll one patient).</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_gen.enroll.time">gen.enroll.time</code></td>
<td>
<p>Method to generate enrollment time. Uniform
distribution is used when <code>gen.enroll.time="uniform"</code>. Exponential
distribution is used when <code>gen.enroll.time="exponential"</code>. The default
value is <code>gen.enroll.time="uniform"</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_stopping.npts">stopping.npts</code></td>
<td>
<p>Early study termination criteria for the number of
patients. If the number of patients at the current dose reaches this
criteria, the study is terminated. The default value is
<code>stopping.npts=size.cohort*n.cohort</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_stopping.prob.t">stopping.prob.T</code></td>
<td>
<p>Early study termination criteria for toxicity,
taking a value between 0 and 1. If the posterior probability that toxicity
outcome is less than the target toxicity probability (<code>phi</code>) is larger than
this criteria, the dose levels are eliminated from the study. The default
value is <code>stopping.prob.T=0.95</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_stopping.prob.e">stopping.prob.E</code></td>
<td>
<p>Early study termination criteria for efficacy,
taking a value between 0 and 1. If the posterior probability that efficacy
outcome is less than the minimum efficacy probability (<code>delta1</code>) is larger
than this criteria, the dose levels are eliminated from the study.
The default value is <code>stopping.prob.E=0.99</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_estpt.method">estpt.method</code></td>
<td>
<p>Method to estimate the efficacy probability. Fractional
polynomial logistic regression is used when <code>estpt.method="fp.logistic"</code>.
Model averaging of multiple unimodal isotopic regression is used when
<code>estpt.method="multi.iso"</code>. Observed efficacy probability is used when
<code>estpt.method="obs.prob"</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_obd.method">obd.method</code></td>
<td>
<p>Method to select the optimal biological dose. Utility
defined by weighted function is used when <code>obd.method="utility.weighted"</code>.
Utility defined by truncated linear function is used when
<code>obd.method="utility.truncated.linear"</code>. Utility defined by scoring is
used when <code>obd.method="utility.scoring"</code>. Highest estimated efficacy
probability is used when <code>obd.method="max.effprob"</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_w1">w1</code></td>
<td>
<p>Weight for toxicity-efficacy trade-off in utility defined by
weighted function. This must be specified when using
<code>obd.method="utility.weighted"</code>. The default value is <code>w1=0.33</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_w2">w2</code></td>
<td>
<p>Weight for penalty imposed on toxic doses in utility defined by
weighted function. This must be specified when using
<code>obd.method="utility.weighted"</code>. The default value is <code>w2=1.09</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_plow.ast">plow.ast</code></td>
<td>
<p>Lower threshold of toxicity linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>plow.ast=phi1</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_pupp.ast">pupp.ast</code></td>
<td>
<p>Upper threshold of toxicity linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>pupp.ast=phi2</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_qlow.ast">qlow.ast</code></td>
<td>
<p>Lower threshold of efficacy linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>qlow.ast=delta1/2</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_qupp.ast">qupp.ast</code></td>
<td>
<p>Upper threshold of efficacy linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>qupp.ast=delta</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_psi00">psi00</code></td>
<td>
<p>Score for toxicity=no and efficacy=no in utility defined by
scoring. This must be specified when using <code>obd.method="utility.scoring"</code>.
The default value is <code>psi00=40</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_psi11">psi11</code></td>
<td>
<p>Score for toxicity=yes and efficacy=yes in utility defined by
scoring. This must be specified when using <code>obd.method="utility.scoring"</code>.
The default value is <code>psi11=60</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_n.sim">n.sim</code></td>
<td>
<p>Number of simulated trial. The default value is
<code>n.sim=1000</code>.</p>
</td></tr>
<tr><td><code id="tite.boinet_+3A_seed.sim">seed.sim</code></td>
<td>
<p>Seed for random number generator. The default value is
<code>seed.sim=100</code>.</p>
</td></tr>
</table>


<h3>Details</h3>

<p>The <code>tite.boinet</code> is a function which generates the operating
characteristics of the time-to-event Bayesian optimal interval design to
accelerate dose-finding based on both efficacy and toxicity outcomes
(TITE-BOIN-ET design) by a simulation study. Users can specify a
variety of study settings to simulate studies, and choose methods to estimate
the efficacy probability and to select the optimal biological dose. The
operating characteristics of the design are summarized by the percentage of
times that each dose level was selected as optimal biological dose and the
average number of patients who were treated at each dose level. The
percentage of times that the study was terminated and the expected study
duration are also provided.
</p>


<h3>Value</h3>

<p>The <code>tite.boinet</code> returns a list containing the following components:
</p>
<table role = "presentation">
<tr><td><code>toxprob</code></td>
<td>
<p>True toxicity probability.</p>
</td></tr>
<tr><td><code>effprob</code></td>
<td>
<p>True efficacy probability.</p>
</td></tr>
<tr><td><code>phi</code></td>
<td>
<p>Target toxicity probability.</p>
</td></tr>
<tr><td><code>delta</code></td>
<td>
<p>Target efficacy probability.</p>
</td></tr>
<tr><td><code>lambda1</code></td>
<td>
<p>Lower toxicity boundary in dose escalation/de-escalation.</p>
</td></tr>
<tr><td><code>lambda2</code></td>
<td>
<p>Upper toxicity boundary in dose escalation/de-escalation.</p>
</td></tr>
<tr><td><code>eta1</code></td>
<td>
<p>Lower efficacy boundary in dose escalation/de-escalation.</p>
</td></tr>
<tr><td><code>tau.T</code></td>
<td>
<p>Toxicity assessment windows (days).</p>
</td></tr>
<tr><td><code>tau.E</code></td>
<td>
<p>Efficacy assessment windows (days).</p>
</td></tr>
<tr><td><code>accrual</code></td>
<td>
<p>Accrual rate (days) (average number of days necessary to
enroll one patient).</p>
</td></tr>
<tr><td><code>estpt.method</code></td>
<td>
<p>Method to estimate the efficacy probability.</p>
</td></tr>
<tr><td><code>obd.method</code></td>
<td>
<p>Method to select the optimal biological dose.</p>
</td></tr>
<tr><td><code>n.patient</code></td>
<td>
<p>Average number of patients who were treated at each dose
level</p>
</td></tr>
<tr><td><code>prop.select</code></td>
<td>
<p>Percentage of times that each dose level was selected as
optimal biological dose.</p>
</td></tr>
<tr><td><code>prop.stop</code></td>
<td>
<p>Percentage of times that the study was terminated and
optimal biological dose was not selected.</p>
</td></tr>
<tr><td><code>duration</code></td>
<td>
<p>Expected study duration (days)</p>
</td></tr>
</table>


<h3>References</h3>

<p>Takeda K, Morita S, Taguri M. TITE-BOIN-ET: Time-to-event Bayesian optimal
interval design to accelerate dose-finding based on both efficacy and
toxicity outcomes. <em>Pharmaceutical Statistics</em> 2020; 19(3):335-349.
</p>
<p>Yamaguchi Y, Takeda K, Yoshida S, Maruo K. Optimal biological dose selection
in dose-finding trials with model-assisted designs based on efficacy and
toxicity: a simulation study. <em>Journal of Biopharmaceutical Statistics</em> 2023;
doi: 10.1080/10543406.2023.2202259.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>n.dose      &lt;- 6
start.dose  &lt;- 1
size.cohort &lt;- 3
n.cohort    &lt;- 12

toxprob &lt;- c(0.01,0.03,0.06,0.12,0.18,0.30)
effprob &lt;- c(0.06,0.08,0.15,0.25,0.40,0.80)

phi   &lt;- 0.33
delta &lt;- 0.70

tau.T   &lt;- 30
tau.E   &lt;- 45
accrual &lt;- 10

estpt.method &lt;- "obs.prob"
obd.method   &lt;- "max.effprob"

n.sim &lt;- 10

tite.boinet(
  n.dose=n.dose, start.dose=start.dose,
  size.cohort=size.cohort, n.cohort=n.cohort,
  toxprob=toxprob, effprob=effprob,
  phi=phi, delta=delta,
  tau.T=tau.T, tau.E=tau.E, accrual=accrual,
  estpt.method=estpt.method, obd.method=obd.method,
  n.sim=n.sim)
</code></pre>

<hr>
<h2 id='tite.gboinet'>Conducting simulation study of TITE-gBOIN-ET design</h2><span id='topic+tite.gboinet'></span>

<h3>Description</h3>

<p>Time-to-event generalized Bayesian optimal interval design to
accelerate dose-finding accounting for ordinal graded efficacy and toxicity
outcomes (TITE-gBOIN-ET design) is
implemented under a scenario specified. Operating characteristics of the
design are summarized by the percentage of times that each dose level was
selected as optimal biological dose and the average number of patients who
were treated at each dose level.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>tite.gboinet(
  n.dose, start.dose, size.cohort, n.cohort,
  toxprob, effprob, sev.weight, res.weight,
  phi, phi1=phi*0.1, phi2=phi*1.4, delta, delta1=delta*0.6,
  alpha.T1=0.5, alpha.E1=0.5, tau.T, tau.E,
  te.corr=0.2, gen.event.time="weibull",
  accrual, gen.enroll.time="uniform",
  stopping.npts=size.cohort*n.cohort,
  stopping.prob.T=0.95, stopping.prob.E=0.99,
  estpt.method, obd.method,
  w1=0.33, w2=1.09,
  plow.ast=phi1, pupp.ast=phi2, qlow.ast=delta1/2, qupp.ast=delta,
  psi00=40, psi11=60,
  n.sim=1000, seed.sim=100)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="tite.gboinet_+3A_n.dose">n.dose</code></td>
<td>
<p>Number of dose.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_start.dose">start.dose</code></td>
<td>
<p>Starting dose. The lowest dose is generally recommended.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_size.cohort">size.cohort</code></td>
<td>
<p>Cohort size.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_n.cohort">n.cohort</code></td>
<td>
<p>Number of cohort.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_toxprob">toxprob</code></td>
<td>
<p>Vector of true toxicity probability.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_effprob">effprob</code></td>
<td>
<p>Vector of true efficacy probability.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_sev.weight">sev.weight</code></td>
<td>
<p>Vector of weight for toxicity category.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_res.weight">res.weight</code></td>
<td>
<p>Vector of weight for efficacy category.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_phi">phi</code></td>
<td>
<p>Target toxicity probability.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_phi1">phi1</code></td>
<td>
<p>Highest toxicity probability that is deemed sub-therapeutic such
that dose-escalation should be pursued. The default value is
<code>phi1=phi*0.1</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_phi2">phi2</code></td>
<td>
<p>Lowest toxicity probability that is deemed overly toxic such that
dose de-escalation is needed. The default value is <code>phi2=phi*1.4</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_delta">delta</code></td>
<td>
<p>Target efficacy probability.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_delta1">delta1</code></td>
<td>
<p>Minimum probability deemed efficacious such that the dose
levels with less than delta1 are considered sub-therapeutic.
The default value is <code>delta1=delta*0.6</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_alpha.t1">alpha.T1</code></td>
<td>
<p>Probability that toxicity event occurs in the late half of
toxicity assessment window. The default value is <code>alpha.T1=0.5</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_alpha.e1">alpha.E1</code></td>
<td>
<p>Probability that efficacy event occurs in the late half of
assessment window. The default value is <code>alpha.E1=0.5</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_tau.t">tau.T</code></td>
<td>
<p>Toxicity assessment windows (days).</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_tau.e">tau.E</code></td>
<td>
<p>Efficacy assessment windows (days).</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_te.corr">te.corr</code></td>
<td>
<p>Correlation between toxicity and efficacy probability,
specified as Gaussian copula parameter. The default value is
<code>te.corr=0.2</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_gen.event.time">gen.event.time</code></td>
<td>
<p>Method to generate the time to first toxicity and
efficacy outcome. Weibull distribution is used when
<code>gen.event.time="weibull"</code>. Uniform distribution is used when
<code>gen.event.time="uniform"</code>. The default value is
<code>gen.event.time="weibull"</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_accrual">accrual</code></td>
<td>
<p>Accrual rate (days) (average number of days necessary to
enroll one patient).</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_gen.enroll.time">gen.enroll.time</code></td>
<td>
<p>Method to generate enrollment time. Uniform
distribution is used when <code>gen.enroll.time="uniform"</code>. Exponential
distribution is used when <code>gen.enroll.time="exponential"</code>. The default
value is <code>gen.enroll.time="uniform"</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_stopping.npts">stopping.npts</code></td>
<td>
<p>Early study termination criteria for the number of
patients. If the number of patients at the current dose reaches this
criteria, the study is terminated. The default value is
<code>stopping.npts=size.cohort*n.cohort</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_stopping.prob.t">stopping.prob.T</code></td>
<td>
<p>Early study termination criteria for toxicity,
taking a value between 0 and 1. If the posterior probability that toxicity
outcome is less than the target toxicity probability (<code>phi</code>) is larger than
this criteria, the dose levels are eliminated from the study. The default
value is <code>stopping.prob.T=0.95</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_stopping.prob.e">stopping.prob.E</code></td>
<td>
<p>Early study termination criteria for efficacy,
taking a value between 0 and 1. If the posterior probability that efficacy
outcome is less than the minimum efficacy probability (<code>delta1</code>) is larger
than this criteria, the dose levels are eliminated from the study.
The default value is <code>stopping.prob.E=0.99</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_estpt.method">estpt.method</code></td>
<td>
<p>Method to estimate the efficacy probability. Fractional
polynomial logistic regression is used when <code>estpt.method="fp.logistic"</code>.
Model averaging of multiple unimodal isotopic regression is used when
<code>estpt.method="multi.iso"</code>. Observed efficacy probability is used when
<code>estpt.method="obs.prob"</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_obd.method">obd.method</code></td>
<td>
<p>Method to select the optimal biological dose. Utility
defined by weighted function is used when <code>obd.method="utility.weighted"</code>.
Utility defined by truncated linear function is used when
<code>obd.method="utility.truncated.linear"</code>. Utility defined by scoring is
used when <code>obd.method="utility.scoring"</code>. Highest estimated efficacy
probability is used when <code>obd.method="max.effprob"</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_w1">w1</code></td>
<td>
<p>Weight for toxicity-efficacy trade-off in utility defined by
weighted function. This must be specified when using
<code>obd.method="utility.weighted"</code>. The default value is <code>w1=0.33</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_w2">w2</code></td>
<td>
<p>Weight for penalty imposed on toxic doses in utility defined by
weighted function. This must be specified when using
<code>obd.method="utility.weighted"</code>. The default value is <code>w2=1.09</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_plow.ast">plow.ast</code></td>
<td>
<p>Lower threshold of toxicity linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>plow.ast=phi1</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_pupp.ast">pupp.ast</code></td>
<td>
<p>Upper threshold of toxicity linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>pupp.ast=phi2</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_qlow.ast">qlow.ast</code></td>
<td>
<p>Lower threshold of efficacy linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>qlow.ast=delta1/2</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_qupp.ast">qupp.ast</code></td>
<td>
<p>Upper threshold of efficacy linear truncated function. This
must be specified when using <code>obd.method="utility.truncated.linear"</code>.
The default value is <code>qupp.ast=delta</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_psi00">psi00</code></td>
<td>
<p>Score for toxicity=no and efficacy=no in utility defined by
scoring. This must be specified when using <code>obd.method="utility.scoring"</code>.
The default value is <code>psi00=40</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_psi11">psi11</code></td>
<td>
<p>Score for toxicity=yes and efficacy=yes in utility defined by
scoring. This must be specified when using <code>obd.method="utility.scoring"</code>.
The default value is <code>psi11=60</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_n.sim">n.sim</code></td>
<td>
<p>Number of simulated trial. The default value is
<code>n.sim=1000</code>.</p>
</td></tr>
<tr><td><code id="tite.gboinet_+3A_seed.sim">seed.sim</code></td>
<td>
<p>Seed for random number generator. The default value is
<code>seed.sim=100</code>.</p>
</td></tr>
</table>


<h3>Details</h3>

<p>The <code>tite.gboinet</code> is a function which generates the operating
characteristics of the time-to-event generalized Bayesian optimal interval
design to accelerate dose-finding accounting for ordinal graded efficacy and
toxicity outcomes
(TITE-gBOIN-ET design) by a simulation study. Users can specify a
variety of study settings to simulate studies, and choose methods to estimate
the efficacy probability and to select the optimal biological dose. The
operating characteristics of the design are summarized by the percentage of
times that each dose level was selected as optimal biological dose and the
average number of patients who were treated at each dose level. The
percentage of times that the study was terminated and the expected study
duration are also provided.
</p>


<h3>Value</h3>

<p>The <code>tite.gboinet</code> returns a list containing the following components:
</p>
<table role = "presentation">
<tr><td><code>toxprob</code></td>
<td>
<p>True toxicity probability.</p>
</td></tr>
<tr><td><code>effprob</code></td>
<td>
<p>True efficacy probability.</p>
</td></tr>
<tr><td><code>nETS</code></td>
<td>
<p>Normalized equivalent toxicity score.</p>
</td></tr>
<tr><td><code>nEES</code></td>
<td>
<p>Normalized equivalent efficacy score.</p>
</td></tr>
<tr><td><code>phi</code></td>
<td>
<p>Target toxicity probability.</p>
</td></tr>
<tr><td><code>delta</code></td>
<td>
<p>Target efficacy probability.</p>
</td></tr>
<tr><td><code>lambda1</code></td>
<td>
<p>Lower toxicity boundary in dose escalation/de-escalation.</p>
</td></tr>
<tr><td><code>lambda2</code></td>
<td>
<p>Upper toxicity boundary in dose escalation/de-escalation.</p>
</td></tr>
<tr><td><code>eta1</code></td>
<td>
<p>Lower efficacy boundary in dose escalation/de-escalation.</p>
</td></tr>
<tr><td><code>tau.T</code></td>
<td>
<p>Toxicity assessment windows (days).</p>
</td></tr>
<tr><td><code>tau.E</code></td>
<td>
<p>Efficacy assessment windows (days).</p>
</td></tr>
<tr><td><code>accrual</code></td>
<td>
<p>Accrual rate (days) (average number of days necessary to
enroll one patient).</p>
</td></tr>
<tr><td><code>estpt.method</code></td>
<td>
<p>Method to estimate the efficacy probability.</p>
</td></tr>
<tr><td><code>obd.method</code></td>
<td>
<p>Method to select the optimal biological dose.</p>
</td></tr>
<tr><td><code>n.patient</code></td>
<td>
<p>Average number of patients who were treated at each dose
level</p>
</td></tr>
<tr><td><code>prop.select</code></td>
<td>
<p>Percentage of times that each dose level was selected as
optimal biological dose.</p>
</td></tr>
<tr><td><code>prop.stop</code></td>
<td>
<p>Percentage of times that the study was terminated and
optimal biological dose was not selected.</p>
</td></tr>
<tr><td><code>duration</code></td>
<td>
<p>Expected study duration (days)</p>
</td></tr>
</table>


<h3>References</h3>

<p>Takeda K, Yamaguchi Y, Taguri M, Morita S. TITE-gBOIN-ET: Time-to-event
generalized Bayesian optimal interval design to accelerate dose-finding
accounting for ordinal graded efficacy and toxicity outcomes.
<em>Biometrical Journal</em> 2023 (in press).
</p>
<p>Yamaguchi Y, Takeda K, Yoshida S, Maruo K. Optimal biological dose selection
in dose-finding trials with model-assisted designs based on efficacy and
toxicity: a simulation study. <em>Journal of Biopharmaceutical Statistics</em> 2023;
doi: 10.1080/10543406.2023.2202259.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>n.dose      &lt;- 6
start.dose  &lt;- 1
size.cohort &lt;- 3
n.cohort    &lt;- 12

toxprob &lt;- rbind(c(0.94,0.87,0.79,0.68,0.62,0.50),
                 c(0.05,0.10,0.15,0.20,0.20,0.20),
                 c(0.01,0.03,0.05,0.10,0.15,0.25),
                 c(0.00,0.00,0.01,0.02,0.03,0.05))
effprob &lt;- rbind(c(0.64,0.52,0.45,0.35,0.20,0.05),
                 c(0.30,0.40,0.40,0.40,0.40,0.15),
                 c(0.05,0.05,0.10,0.15,0.20,0.35),
                 c(0.01,0.03,0.05,0.10,0.20,0.45))

sev.weight &lt;- c(0.00,0.50,1.00,1.50)
res.weight &lt;- c(0.00,0.25,1.00,3.00)

phi   &lt;- 0.33
delta &lt;- 0.70

tau.T   &lt;- 30
tau.E   &lt;- 45
accrual &lt;- 10

estpt.method &lt;- "obs.prob"
obd.method   &lt;- "max.effprob"

n.sim &lt;- 10

tite.gboinet(
  n.dose=n.dose, start.dose=start.dose,
  size.cohort=size.cohort, n.cohort=n.cohort,
  toxprob=toxprob, effprob=effprob,
  sev.weight=sev.weight, res.weight=res.weight,
  phi=phi, delta=delta,
  tau.T=tau.T, tau.E=tau.E, accrual=accrual,
  estpt.method=estpt.method, obd.method=obd.method,
  n.sim=n.sim)
</code></pre>

<hr>
<h2 id='utility.scoring'>Utility defined by scoring</h2><span id='topic+utility.scoring'></span>

<h3>Description</h3>

<p>Given estimated toxicity and efficacy probabilities, the utility which is
defined by scoring is calculated.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>utility.scoring(probt, probe, psi00, psi11)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="utility.scoring_+3A_probt">probt</code></td>
<td>
<p>Estimated toxicity probability.</p>
</td></tr>
<tr><td><code id="utility.scoring_+3A_probe">probe</code></td>
<td>
<p>Estimated efficacy probability.</p>
</td></tr>
<tr><td><code id="utility.scoring_+3A_psi00">psi00</code></td>
<td>
<p>Score for toxicity=no and efficacy=no.</p>
</td></tr>
<tr><td><code id="utility.scoring_+3A_psi11">psi11</code></td>
<td>
<p>Score for toxicity=yes and efficacy=yes.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>The <code>utility.scoring</code> returns a utility value defined by the scoring.
</p>

<hr>
<h2 id='utility.truncated.linear'>Utility defined by truncated linear function</h2><span id='topic+utility.truncated.linear'></span>

<h3>Description</h3>

<p>Given estimated toxicity and efficacy probabilities, the utility which is
defined by truncated linear functions is Calculated.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>utility.truncated.linear(probt, probe, tlow, tupp, elow, eupp)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="utility.truncated.linear_+3A_probt">probt</code></td>
<td>
<p>Estimated toxicity probability</p>
</td></tr>
<tr><td><code id="utility.truncated.linear_+3A_probe">probe</code></td>
<td>
<p>Estimated efficacy probability</p>
</td></tr>
<tr><td><code id="utility.truncated.linear_+3A_tlow">tlow</code></td>
<td>
<p>Lower threshold of toxicity linear truncated function.</p>
</td></tr>
<tr><td><code id="utility.truncated.linear_+3A_tupp">tupp</code></td>
<td>
<p>Upper threshold of toxicity linear truncated function.</p>
</td></tr>
<tr><td><code id="utility.truncated.linear_+3A_elow">elow</code></td>
<td>
<p>Lower threshold of efficacy linear truncated function.</p>
</td></tr>
<tr><td><code id="utility.truncated.linear_+3A_eupp">eupp</code></td>
<td>
<p>Upper threshold of efficacy linear truncated function.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>The <code>utility.truncated.linear</code> returns a utility value defined by
the truncated linear functions.
</p>

<hr>
<h2 id='utility.weighted'>Utility defined by weighted function</h2><span id='topic+utility.weighted'></span>

<h3>Description</h3>

<p>Given estimated toxicity and efficacy probabilities, the utility which is
defined by a weighted function is Calculated.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>utility.weighted(probt, probe, w1, w2, tox.upper)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="utility.weighted_+3A_probt">probt</code></td>
<td>
<p>Estimated toxicity probability.</p>
</td></tr>
<tr><td><code id="utility.weighted_+3A_probe">probe</code></td>
<td>
<p>Estimated efficacy probability.</p>
</td></tr>
<tr><td><code id="utility.weighted_+3A_w1">w1</code></td>
<td>
<p>Weight for toxicity-efficacy trade-off.</p>
</td></tr>
<tr><td><code id="utility.weighted_+3A_w2">w2</code></td>
<td>
<p>Weight for penalty imposed on toxic doses.</p>
</td></tr>
<tr><td><code id="utility.weighted_+3A_tox.upper">tox.upper</code></td>
<td>
<p>Upper bound of toxicity probability.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>The <code>utility.weighted</code> returns a utility value defined by
the weighted function.
</p>

</main>

</div>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/prism.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/components/prism-r.min.js"></script>
</body></html>
